Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From 4basebio AG
Plus deals involving LegoChem/Pyxix, Biohaven/Sosei Heptares, Kyowa Kirin/Helsinn, Dr. Reddy’s/Glenmark, Eisai/Wren, KoBioLabs/Kolmar Korea, Y-Biologics/Pierre Fabre, Generex/Chinese consortium.
Gossamer took an infrequently used path to go public during a US government shutdown that's kept the SEC from processing new offerings. Also, IPO filings (and withdrawals) and follow-on offerings continued during the shutdown, while VC deals keep up a brisk pace.
Also, TapImmune merger with Marker could yield T-cell therapies that address multiple tumor-associated antigens with a better safety profile than CAR-T therapy. Bluebird and Medigene expand their TCR therapy collaboration.
Women in leadership roles has become a much discussed issue for the biopharma industry, but less attention seems to be focused on racial diversity. Scrip's panel talks about challenges and opportunities, and offers advice for next generation employees.
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Contract Manufacturing Organization
- Antisense, Oligonucleotides
- Other Names / Subsidiaries
- Abcam plc
- C.B.S. Scientific Company Inc.
- Expedeon Ltd.
- Expedeon AG
- Innova Biosciences Ltd.
- LION Bioscience AG
- SYGNIS AG
- SYGNIS Pharma AG
- TGR Biosciences PTY LTD